Home
Conditions
Substance Withdrawal Syndrome

Clinical trial condition

Substance Withdrawal Syndrome

Explore clinical trials studying Substance Withdrawal Syndrome. Study availability and eligibility vary by location and protocol.

23 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Substance Withdrawal Syndrome trial results

Completed

Efficacy of XYZ for Withdrawal Syndrome

NCT07543809

Conditions: Chemically-Induced Disorders, Mental Disorders, Substance Withdrawal Syndrome, +1 more
Locations: Chongqing Jiangbei Hospital of Traditional Chinese Medicine Chongqing, Chongqing Municipality, China

View Trial Details

Completed

Signs and Symptoms of Opioid-associated Iatrogenic Withdrawal in Critically Ill Adults

NCT03435614

Conditions: Chemically-Induced Disorders, Mental Disorders, Substance Withdrawal Syndrome, +1 more
Locations: McGill University Health Centre Montreal, Quebec, Canada

View Trial Details

Completed

Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED

NCT02643355

Conditions: Chemically-Induced Disorders, Disease Attributes, Emergencies, +5 more
Locations: Hennepin County Medical Center Minneapolis, Minnesota, United States

View Trial Details

Completed

Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?

NCT02825459

Conditions: Behavior, Chemically-Induced Disorders, Harm Reduction, +8 more
Locations: Battelle Memorial Institute Baltimore, Maryland, United States

University of Vermont Burlington, Vermont, United States

View Trial Details

Completed

Nicotine Replacement Therapy in the Intensive Care Unit

NCT01362959

Conditions: Aberrant Motor Behavior in Dementia, Behavior, Behavioral Symptoms, +16 more
Locations: Gelderse Vallei Hospital Ede, Gelderland, Netherlands

Deventer Hospital Deventer, Overijssel, Netherlands

View Trial Details

Completed

Opioid Withdrawal Symptoms in Critically Ill Patients

NCT03374722

Conditions: Chemically-Induced Disorders, Critical Illness, Disease Attributes, +5 more
Locations: Faculty of Pharmacy, Mahidol University Ratchathewi, Bangkok, Thailand

View Trial Details

Completed

Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction

NCT02801357

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +5 more
Locations: Overland Park, Kansas, United States

View Trial Details

Completed

Effect of Ondansetron for Withdrawal Symptoms

NCT00695864

Conditions: Chemically-Induced Disorders, Mental Disorders, Substance Withdrawal Syndrome, +1 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal

NCT00980044

Conditions: Chemically-Induced Disorders, Mental Disorders, Substance Withdrawal Syndrome, +1 more
Locations: University of Kentucky Lexington, Kentucky, United States

View Trial Details

Completed

Acute Withdrawal From Smoked Cocaine - 9

NCT00000292

Conditions: Chemically-Induced Disorders, Cocaine-Related Disorders, Mental Disorders, +3 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Substance Withdrawal Syndrome

Substance Withdrawal Syndrome trial results

Related conditions